NextBillion - An Initiative of the William Davidson Institute at the University of Michigan

Wednesday, April 20, 2016

The Abell Foundation has invested $200,000 in Sisu Global Health, a Baltimore-based company that’s developing medical devices for doctors in the developing world.

“Sisu’s business of providing cost-effective medical devices for developing countries and its network of support within its target markets and with international NGOs is compelling,” said Eileen O’Rourke, the Abell Foundation’s chief financial officer, in a statement.

The company’s first device, the Hemafuse, allows doctors to recycle blood from patients with internal bleeding, reducing the need for donor blood.